检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:邹晓 魏涛[2] 刘宏[3] 孙刚 薛龙[2] 王启堂 王梅
机构地区:[1]青岛市中心医院查体中心,266042 [2]青岛市市立医院,266011 [3]青岛市精神卫生中心,266034
出 处:《放射免疫学杂志》2006年第3期180-181,共2页Journal of Radioimmanology
摘 要:目的:本文以影像学检查为参照,研究血清PⅢNP在乳腺癌患者复发监测中的应用价值。方法:选择成功随访36例术后复发转移乳腺癌患者为对象(其中肝转移21例,骨转移10例,肺转移5例)。乳腺癌病理分期:Ⅱ期8例、Ⅲ期28例。采用放射免疫分析乳腺癌患者术前、术后血清PⅢNP水平及CA15—3水平。36例乳腺癌患者术后均定期进行影像学检查。结果:血清PⅢNP预测复发早于影像学指标(6—9)个月,比CA15—3早3个月。结论:PⅢNP作为乳腺癌复发的熏要参考指标,术后PⅢNP水平较术前下降不明显或者持续升高,提示复发。血清PⅢNP预测复发较CA15—3及影像学早。Objective To compare the results of serum aminoterminal peptide of type Ⅲ procollagen ( PⅢNP) levels monitoring vs that with imaging studies for early detection of recurrence of breast carcinoma after surgical treatment. Methods Patients with breast cancer were examined for serum PⅢNP and CA15-3 levels measurement (with RIA) and imaging studies both before and every three months after operation up to 18 months. Elevation of the postoperative lowered tumor markers levels to above 60% of the preoperative values was designated as possible development of recurrence and the three - monthly examination was continued until definite recurrence was demonstrated with imaging studies. If possible, second operation was performed. Results Altogether, 36 patients were found to be with proven recurrences ( hepatic 26, osseous 10, pulmonary 5 ). Elevation of the serum PIII NP level to above 60% of the pre - operative level usually took place 3 months earlier than that of CA15 - 3 level and 6 ~ 9 months earlier than the time of imaging study demonstration. Conclusion For early detection of post - operative recurrence of breast cancer, serum P ⅢNP level monitoring was more sensitive than CA15 -3 monitoring and imaging studies. A higher then expected level of serum PⅢNP post -operatively would warrant close observation.
关 键 词:Ⅲ型前胶原氨基末端前肽 乳腺肿瘤 影像学
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.3